J Katz1, D Gilbert, H A Quigley, A Sommer. 1. Department of International Health, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland 21205-2103, USA.
Abstract
PURPOSE: The authors estimated the prevalence and rates of progressive visual field loss in glaucoma patients followed annually for a median of 6.3 years. METHODS: Linear regression was used to estimate rates of progression of mean deviation, corrected pattern standard deviation (CPSD), clusters of locations based on the Glaucoma Hemifield Test (GHT), and location specific changes in C-30-2 fields of the Humphrey Analyzer. RESULTS: Sixty-seven eyes of 56 patients whose first two consecutive fields were abnormal on GHT were included. Almost all patients were under treatment or had undergone surgery for glaucoma. Visual field deteriorated in 19 (28%) eyes based on worsening of one or more CPSD, GHT clusters, or individual test locations (regression slopes significantly different from zero). Corrected pattern standard deviation deteriorated in 5 eyes, at least one GHT cluster deteriorated in 17 eyes, and one or more individual test locations deteriorated in 15 eyes. For those whose visual field deteriorated, CPSD increased by 0.9 dB/year. Glaucoma Hemifield Test clusters declined by between 1.4 and 2.4 dB/year. Deterioration at individual locations ranged from 1.0 to 5.0 dB/year. Age, but not baseline visual field severity, was predictive of further visual field loss. The odds ratio for the association between progressive visual field loss and thinning of the nerve fiber layer was 1.81 (95% confidence interval: 0.52, 6.33), and 3.78 (95% confidence interval: 0.80, 18.16) for the association between progressive visual field loss and optic disc changes during follow-up based on masked photograph readings. CONCLUSIONS: Less than one in three eyes of patients with glaucoma had any progressive field loss. Average changes in threshold sensitivities of less than 1 dB/year could not be detected with seven fields done over 6 years. Larger changes or increased frequency of visual field testing would need to occur before smaller changes could be detected statistically.
PURPOSE: The authors estimated the prevalence and rates of progressive visual field loss in glaucomapatients followed annually for a median of 6.3 years. METHODS: Linear regression was used to estimate rates of progression of mean deviation, corrected pattern standard deviation (CPSD), clusters of locations based on the Glaucoma Hemifield Test (GHT), and location specific changes in C-30-2 fields of the Humphrey Analyzer. RESULTS: Sixty-seven eyes of 56 patients whose first two consecutive fields were abnormal on GHT were included. Almost all patients were under treatment or had undergone surgery for glaucoma. Visual field deteriorated in 19 (28%) eyes based on worsening of one or more CPSD, GHT clusters, or individual test locations (regression slopes significantly different from zero). Corrected pattern standard deviation deteriorated in 5 eyes, at least one GHT cluster deteriorated in 17 eyes, and one or more individual test locations deteriorated in 15 eyes. For those whose visual field deteriorated, CPSD increased by 0.9 dB/year. Glaucoma Hemifield Test clusters declined by between 1.4 and 2.4 dB/year. Deterioration at individual locations ranged from 1.0 to 5.0 dB/year. Age, but not baseline visual field severity, was predictive of further visual field loss. The odds ratio for the association between progressive visual field loss and thinning of the nerve fiber layer was 1.81 (95% confidence interval: 0.52, 6.33), and 3.78 (95% confidence interval: 0.80, 18.16) for the association between progressive visual field loss and optic disc changes during follow-up based on masked photograph readings. CONCLUSIONS: Less than one in three eyes of patients with glaucoma had any progressive field loss. Average changes in threshold sensitivities of less than 1 dB/year could not be detected with seven fields done over 6 years. Larger changes or increased frequency of visual field testing would need to occur before smaller changes could be detected statistically.
Authors: Lyne Racette; Jeffrey M Liebmann; Christopher A Girkin; Linda M Zangwill; Sonia Jain; Lida M Becerra; Felipe A Medeiros; Christopher Bowd; Robert N Weinreb; Catherine Boden; Pamela A Sample Journal: Arch Ophthalmol Date: 2010-05
Authors: Jong Rak Lee; Jiyun Lee; Jong-Eun Lee; Jin Young Lee; Michael S Kook Journal: Graefes Arch Clin Exp Ophthalmol Date: 2016-10-06 Impact factor: 3.117
Authors: Siamak Yousefi; Tobias Elze; Louis R Pasquale; Osamah Saeedi; Mengyu Wang; Lucy Q Shen; Sarah R Wellik; Carlos G De Moraes; Jonathan S Myers; Michael V Boland Journal: Ophthalmology Date: 2020-03-10 Impact factor: 12.079